Connection

IN YOUNG PARK to Humans

This is a "connection" page, showing publications IN YOUNG PARK has written about Humans.
Connection Strength

0.134
  1. Engineering of human brain organoids with a functional vascular-like system. Nat Methods. 2019 11; 16(11):1169-1175.
    View in: PubMed
    Score: 0.014
  2. Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1a. Nat Commun. 2018 07 03; 9(1):2583.
    View in: PubMed
    Score: 0.013
  3. Methylated a-tubulin antibodies recognize a new microtubule modification on mitotic microtubules. MAbs. 2016 Nov/Dec; 8(8):1590-1597.
    View in: PubMed
    Score: 0.011
  4. Dual Chromatin and Cytoskeletal Remodeling by SETD2. Cell. 2016 Aug 11; 166(4):950-962.
    View in: PubMed
    Score: 0.011
  5. Investigation of Rett syndrome using pluripotent stem cells. J Cell Biochem. 2013 Nov; 114(11):2446-53.
    View in: PubMed
    Score: 0.009
  6. Disease-specific induced pluripotent stem cells. Cell. 2008 Sep 05; 134(5):877-86.
    View in: PubMed
    Score: 0.006
  7. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008 Jan 10; 451(7175):141-6.
    View in: PubMed
    Score: 0.006
  8. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology. 2007 Apr; 132(4):1476-94.
    View in: PubMed
    Score: 0.006
  9. Scalable production of tissue-like vascularized liver organoids from human PSCs. Exp Mol Med. 2023 09; 55(9):2005-2024.
    View in: PubMed
    Score: 0.005
  10. Molecular determinants for a-tubulin methylation by SETD2. J Biol Chem. 2021 07; 297(1):100898.
    View in: PubMed
    Score: 0.004
  11. Implantation of the clinical-grade human neural stem cell line, CTX0E03, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease. Stem Cells. 2020 08; 38(8):936-947.
    View in: PubMed
    Score: 0.004
  12. SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma. Cancer Res. 2018 06 15; 78(12):3135-3146.
    View in: PubMed
    Score: 0.003
  13. Glutamine synthetase mediates sorafenib sensitivity in ?-catenin-active hepatocellular carcinoma cells. Exp Mol Med. 2018 01 05; 50(1):e421.
    View in: PubMed
    Score: 0.003
  14. Enhanced Therapeutic and Long-Term Dynamic Vascularization Effects of Human Pluripotent Stem Cell-Derived Endothelial Cells Encapsulated in a Nanomatrix Gel. Circulation. 2017 Nov 14; 136(20):1939-1954.
    View in: PubMed
    Score: 0.003
  15. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas. Cancer Res. 2017 10 01; 77(19):5313-5326.
    View in: PubMed
    Score: 0.003
  16. Bisulfite-independent analysis of CpG island methylation enables genome-scale stratification of single cells. Nucleic Acids Res. 2017 Jun 02; 45(10):e77.
    View in: PubMed
    Score: 0.003
  17. Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2. Circ Res. 2017 Mar 03; 120(5):848-861.
    View in: PubMed
    Score: 0.003
  18. Quantification of histone modifications by parallel-reaction monitoring: a method validation. Anal Chem. 2015 Oct 06; 87(19):10006-14.
    View in: PubMed
    Score: 0.003
  19. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma. Oncogene. 2016 Mar 24; 35(12):1565-74.
    View in: PubMed
    Score: 0.003
  20. Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells. Blood. 2013 Aug 15; 122(7):1162-73.
    View in: PubMed
    Score: 0.002
  21. Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation. 2012 Oct 02; 126(14):1695-704.
    View in: PubMed
    Score: 0.002
  22. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011 Nov 27; 29(12):1132-44.
    View in: PubMed
    Score: 0.002
  23. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Ann Neurol. 2011 Sep; 70(3):402-9.
    View in: PubMed
    Score: 0.002
  24. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet. 2010 Dec; 42(12):1113-7.
    View in: PubMed
    Score: 0.002
  25. Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome). Blood. 2011 Jan 20; 117(3):839-47.
    View in: PubMed
    Score: 0.002
  26. Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev Rep. 2010 Jun; 6(2):270-81.
    View in: PubMed
    Score: 0.002
  27. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Gastroenterology. 2010 May; 138(5):1898-908.
    View in: PubMed
    Score: 0.002
  28. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol. 2009 Apr; 27(4):353-60.
    View in: PubMed
    Score: 0.002
  29. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res. 2008 Jun 01; 68(11):4210-20.
    View in: PubMed
    Score: 0.002
  30. A new compound from Micromonospora sp. SA246, 9-hydroxycrisamicin-A, activates hepatitis B virus replication. Biochem Biophys Res Commun. 2004 Jul 02; 319(3):859-65.
    View in: PubMed
    Score: 0.001
  31. High-level expression of human lactoferrin in milk of transgenic mice using genomic lactoferrin sequence. J Biochem. 1999 Aug; 126(2):320-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.